metronidazole-based oral suspension indicated for the treatment of protozoal and anaerobic bacterial infections
Amrizole is a metronidazole-based oral suspension indicated for the treatment of protozoal and anaerobic bacterial infections, including giardiasis, amebiasis (intestinal and hepatic), trichomoniasis, and anaerobic infections such as Bacteroides and Clostridium spp.
Attributes
Medical Attributes
Active Ingredient:
Metronidazole
Product Content
How to Use:
• Adults and adolescents ≥ 12 years:
Giardiasis/amebiasis:16 ml three times daily for 5–7 days.
Trichomoniasis: 16 ml twice daily for 5–7 days.
Anaerobic infections: 20 ml every 8 hours for 7–10 days.
• Children 1–12 years: 15–40 mg/kg/day divided into 2–3 doses for 7–10 days (not exceeding 2,000 mg/day).
The link to Amrizole 120ml Suspension has been copied